现金流量表（Apellis Pharmaceuticals Inc）
| 2024年三季报 | 2024年中报 | 2024年一季报 | 2023年年报 | 2023年三季报 | 2023年中报 | 2023年一季报 | 2022年年报 | 2022年三季报 | 2022年中报 | 2022年一季报 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 起始日期 | 2024-01-01 | 2024-01-01 | 2024-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2023-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 | 2022-01-01 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 报表年结日 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 | 1231 |
| 原始币种 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 | 美元 |
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 经营活动产生的现金流量： | |||||||||||
| 净利润(元) | -161,525,000.00 | -104,080,000.00 | -66,423,000.00 | -528,628,000.00 | -440,052,000.00 | -299,815,000.00 | -177,778,000.00 | -652,172,000.00 | -486,181,000.00 | -294,912,000.00 | -138,935,000.00 |
| 折旧及摊销(元) | 2,322,000.00 | 1,207,000.00 | 520,000.00 | 2,001,000.00 | 1,436,000.00 | 956,000.00 | 472,000.00 | 1,946,000.00 | 1,445,000.00 | 992,000.00 | 504,000.00 |
| 基于股票的补偿费(元) | 87,814,000.00 | 60,339,000.00 | 30,349,000.00 | 105,945,000.00 | 79,726,000.00 | 58,101,000.00 | 28,823,000.00 | 91,085,000.00 | 66,844,000.00 | 43,303,000.00 | 20,773,000.00 |
| 资产处置损益(元) | - | - | - | 120,000.00 | 152,000.00 | 19,000.00 | 19,000.00 | - | - | - | - |
| 投资损益(元) | 1,949,000.00 | 1,949,000.00 | - | - | - | - | - | 32,890,000.00 | 32,890,000.00 | - | - |
| 经营业务调整其他项目(元) | 8,936,000.00 | 8,936,000.00 | 6,066,000.00 | 25,996,000.00 | 19,491,000.00 | 13,078,000.00 | 6,633,000.00 | 28,204,000.00 | 23,278,000.00 | 14,907,000.00 | 7,921,000.00 |
| 存货的减少(增加)(元) | -20,776,000.00 | -29,431,000.00 | -14,921,000.00 | -60,647,000.00 | -12,831,000.00 | -17,502,000.00 | 144,000.00 | -69,397,000.00 | -43,436,000.00 | -32,134,000.00 | -16,533,000.00 |
| 预付款项及其他应收款减少(增加)(元) | 15,022,000.00 | 9,832,000.00 | -4,338,000.00 | -1,870,000.00 | -7,681,000.00 | 2,535,000.00 | -107,000.00 | -11,479,000.00 | - | - | - |
| 待摊费用及其他资产(元) | - | - | - | - | - | - | - | - | -5,492,000.00 | 61,372,000.00 | 13,656,000.00 |
| 应收账款及票据减少(增加)(元) | -72,569,000.00 | -97,990,000.00 | -61,415,000.00 | -198,715,000.00 | -161,542,000.00 | -103,186,000.00 | -23,778,000.00 | 2,375,000.00 | 2,010,000.00 | 2,584,000.00 | 3,773,000.00 |
| 应付账款及票据增加(减少)(元) | -399,000.00 | 759,000.00 | -10,730,000.00 | 170,000.00 | -19,450,000.00 | -9,849,000.00 | -5,854,000.00 | 18,689,000.00 | -4,437,000.00 | 2,591,000.00 | -6,371,000.00 |
| 递延收入(元) | 1,903,000.00 | 1,903,000.00 | 3,560,000.00 | - | - | - | - | - | - | - | - |
| 应计费用及其他负债(元) | 19,534,000.00 | -4,308,000.00 | -26,330,000.00 | 34,950,000.00 | 23,099,000.00 | 3,065,000.00 | -23,471,000.00 | -6,312,000.00 | -21,264,000.00 | -17,287,000.00 | 3,652,000.00 |
| 经营业务其他项目(元) | 10,563,000.00 | 9,562,000.00 | 10,679,000.00 | 25,943,000.00 | 20,792,000.00 | 24,823,000.00 | 17,277,000.00 | 50,426,000.00 | 61,342,000.00 | - | - |
| 经营活动产生的现金流量净额(元) | -107,226,000.00 | -141,322,000.00 | -132,983,000.00 | -594,735,000.00 | -496,860,000.00 | -327,775,000.00 | -177,620,000.00 | -513,745,000.00 | -373,001,000.00 | -218,584,000.00 | -111,560,000.00 |
| 投资活动产生的现金流量： | |||||||||||
| 购买固定资产支付的现金(元) | -383,000.00 | -383,000.00 | -293,000.00 | -773,000.00 | -678,000.00 | -631,000.00 | -259,000.00 | -1,524,000.00 | -673,000.00 | -477,000.00 | -86,000.00 |
| 处置固定资产收到的现金(元) | - | - | - | 99,000.00 | - | - | - | - | - | - | - |
| 购买无形资产及其他资产支付的现金(元) | - | - | - | - | - | - | - | - | - | -331,863,000.00 | -331,863,000.00 |
| 处置无形资产及其他资产收到的现金(元) | - | - | - | - | - | - | - | - | - | 143,320,000.00 | 60,000,000.00 |
| 投资支付现金(元) | - | - | - | - | - | - | - | -331,863,000.00 | -331,863,000.00 | - | - |
| 投资业务其他项目(元) | - | - | - | - | - | - | - | 393,280,000.00 | 268,300,000.00 | - | - |
| 投资活动产生的现金流量净额(元) | -383,000.00 | -383,000.00 | -293,000.00 | -674,000.00 | -678,000.00 | -631,000.00 | -259,000.00 | 59,893,000.00 | -64,236,000.00 | -189,020,000.00 | -271,949,000.00 |
| 融资活动产生的现金流量： | |||||||||||
| 发行股份(元) | 3,193,000.00 | 3,193,000.00 | - | 389,765,000.00 | 388,141,000.00 | 388,141,000.00 | 384,387,000.00 | 384,358,000.00 | 382,651,000.00 | 382,651,000.00 | 380,120,000.00 |
| 行使股票期权所得(元) | 13,995,000.00 | 11,439,000.00 | 9,477,000.00 | 71,274,000.00 | 45,809,000.00 | 40,052,000.00 | 17,718,000.00 | 21,483,000.00 | 19,409,000.00 | 8,770,000.00 | 4,000,000.00 |
| 贷款收益(元) | 365,454,000.00 | 365,454,000.00 | - | - | - | - | - | - | - | - | - |
| 发行费用相关(元) | -1,589,000.00 | -1,589,000.00 | - | - | - | - | - | - | - | - | - |
| 筹资业务其他项目(元) | -227,812,000.00 | -227,798,000.00 | 98,735,000.00 | -66,540,000.00 | -35,538,000.00 | -35,527,000.00 | -10,999,000.00 | -40,182,000.00 | -20,455,000.00 | -19,452,000.00 | -7,416,000.00 |
| 融资活动产生的现金流量净额(元) | 153,241,000.00 | 150,699,000.00 | 108,212,000.00 | 394,499,000.00 | 398,412,000.00 | 392,666,000.00 | 391,106,000.00 | 365,659,000.00 | 381,605,000.00 | 371,969,000.00 | 376,704,000.00 |
| 汇率变动影响(元) | 306,000.00 | 133,000.00 | -209,000.00 | 135,000.00 | -449,000.00 | 9,000.00 | 56,000.00 | -488,000.00 | -675,000.00 | -365,000.00 | 64,000.00 |
| 现金及现金等价物期初余额(元) | 352,299,000.00 | 352,299,000.00 | 352,299,000.00 | 553,074,000.00 | 553,075,000.00 | 553,075,000.00 | 553,075,000.00 | 641,755,000.00 | 641,755,000.00 | 641,755,000.00 | 641,755,000.00 |
| 现金及现金等价物增加(减少)额(元) | 45,938,000.00 | 9,127,000.00 | -25,273,000.00 | -200,775,000.00 | -99,575,000.00 | 64,269,000.00 | 213,283,000.00 | -88,681,000.00 | -56,307,000.00 | -36,000,000.00 | -6,741,000.00 |
| 现金及现金等价物期末余额(元) | 398,237,000.00 | 361,426,000.00 | 327,026,000.00 | 352,299,000.00 | 453,500,000.00 | 617,344,000.00 | 766,358,000.00 | 553,074,000.00 | 585,448,000.00 | 605,755,000.00 | 635,014,000.00 |
| 利息支付(元) | 19,446,000.00 | 6,949,000.00 | 1,643,000.00 | - | 3,286,000.00 | 1,643,000.00 | 1,643,000.00 | 5,003,000.00 | 5,003,000.00 | - | 3,360,000.00 |
| 所得税支付(元) | 600,000.00 | - | - | - | 578,000.00 | 384,000.00 | 250,000.00 | 4,915,000.00 | 156,000.00 | - | - |
| 补充资料其他项目(元) | 802,099,000.00 | 722,971,000.00 | 654,309,000.00 | - | 907,000,000.00 | 1,234,688,000.00 | 1,532,716,000.00 | 1,204,234,000.00 | 1,268,982,000.00 | - | - |
| 公告日期 | 2024-11-05 | 2024-08-01 | 2024-05-07 | 2024-02-27 | 2023-11-01 | 2023-07-31 | 2023-05-04 | 2023-02-21 | 2022-11-07 | 2022-08-08 | 2022-05-04 |
| 会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 | 美国会计准则 |
| 审计意见 | |||||||||||
| 核数师 |